Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
9Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
HeartSciences Inc. (HSCS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
17Total relationships
2Distinct source URLs
7High confidence
0.755Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
HeartSciences Inc. Suppliers
Ticker
Name
Confidence
Evidence
MOUNT-SINAI
MOUNT-SINAI
92%
On September 20, 2023, the Company entered into multiple definitive license agreements with Mount Sinai to commercialize a range of AI cardiovascular algorithms developed by Mount Sinai
RUTGERS-THE-STATE-UNIVERSITY-OF-NEW-JERSEY
RUTGERS-THE-STATE-UNIVERSITY-OF-NEW-JERSEY
92%
On November 29, 2022, the Company entered into a multi-year Collaboration Agreement with Rutgers, The State University of New Jersey, to develop AI-ECG algorithms for new or improved ECG indications
ICAHN-SCHOOL-OF-MEDICINE-AT-MOUNT-SINAI
ICAHN-SCHOOL-OF-MEDICINE-AT-MOUNT-SINAI
90%
On September 20, 2023, we entered into multiple definitive license agreements (each a "License Agreement" and collectively, the "License Agreements") with Icahn School of Medicine at Mount Sinai ("Mo…
THE-UNIVERSITY-COURT-OF-THE-UNIVERSITY-OF-GLASGO
THE-UNIVERSITY-COURT-OF-THE-UNIVERSITY-OF-GLASGO
90%
Amendment No. 1 License Agreement by and between the Company and The University Court of The University of Glasgow, dated March 31, 2023
RYLPF
Koninklijke Philips N.V.
72%
Reciprocal relationship from RYLPF graph: Reciprocal relationship from HSCS graph: Reciprocal relationship from RYLPF graph: Reciprocal relationship from HSCS graph: Reciprocal relationship from RYLP…
HeartSciences Inc. Customers
Ticker
Name
Confidence
Evidence
RYLPF
Koninklijke Philips N.V.
72%
Reciprocal relationship from RYLPF graph: Reciprocal relationship from HSCS graph: edical record as a result of a face-to-face visit. Therefore, there is a financial incentive to identify those Medic…
RYLPF
Koninklijke Philips N.V.
72%
edical record as a result of a face-to-face visit. Therefore, there is a financial incentive to identify those Medicare Advantage patients who are sicker, including those who have undiagnosed ailment…
Reciprocal relationship from BAX graph: Reciprocal relationship from HSCS graph: edical record as a result of a face-to-face visit. Therefore, there is a financial incentive to identify those Medicar…
edical record as a result of a face-to-face visit. Therefore, there is a financial incentive to identify those Medicare Advantage patients who are sicker, including those who have undiagnosed ailment…
Reciprocal relationship from GEHC graph: Reciprocal relationship from HSCS graph: Reciprocal relationship from GEHC graph: Reciprocal relationship from HSCS graph: edical record as a result of a face…
edical record as a result of a face-to-face visit. Therefore, there is a financial incentive to identify those Medicare Advantage patients who are sicker, including those who have undiagnosed ailment…
MAXIM-GROUP-LLC
MAXIM-GROUP-LLC
62%
of April 30, 2023. We incurred a net loss of $6.6 million for the year ended April 30, 2024. As of April 30, 2024, we had an accumulated deficit of $67.4 million and working capital of $5.6 million. …
NIHON-KOHDEN-CORPORATION
NIHON-KOHDEN-CORPORATION
62%
edical record as a result of a face-to-face visit. Therefore, there is a financial incentive to identify those Medicare Advantage patients who are sicker, including those who have undiagnosed ailment…
TEMPUS-LABS-INC
TEMPUS-LABS-INC
62%
edical record as a result of a face-to-face visit. Therefore, there is a financial incentive to identify those Medicare Advantage patients who are sicker, including those who have undiagnosed ailment…
HeartSciences Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
HSCS-DEBT-10084
Warrants outstanding: 170637
90%
xbrl warrant detail from xbrl 2025-04-30.
HSCS-DEBT-10085
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-04-30.
HSCS-DEBT
Debt stack $3.9M
90%
Market cache reports total debt of $3.9M.
HeartSciences Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for HeartSciences Inc..
HeartSciences Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for HeartSciences Inc..
